Celerion | Lincoln Celerion CPU

Research site

Location

621 Rose Street, Lincoln, Nebraska, United States of America

Website

http://www.celerion.com

Site insights

Top conditions

Top treatments

Enlicitide Decanoate

MK-0616

Itraconazole

Nicotine

Entinostat

Islatravir

MK-8591

TAK-788

BBT-877

Midazolam

Parent organization

This site is a part of Celerion

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

6 of 145 total trials

A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects

This is a Phase 1, 2-part double-blinded (with respect to NX-5948/placebo), placebo-controlled study. Part 1 is a randomized, 3 period cross-over foo...

Active, not recruiting

Healthy Volunteers

Drug: Matching Placebo

Drug: IP

Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948

This is a Phase 1, 2-period, open-label, single-dose, fixed-sequence study to assess the absolute bioavailability, absorption, metabolism, excretion,...

Enrolling

Healthy Volunteer

Drug: NX-5948

Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products

The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smok...

Active, not recruiting

Tobacco Use

Other: Smoking Abstinence (menthol)

Other: Smoking Abstinence (non-menthol)

First-in-human Study of MRT-6160 in Healthy Subjects

The principal aim of this study is to obtain safety and tolerability data when MRT-6160 is administered orally as single and multiple doses to health...

Enrolling

Healthy Volunteers

Drug: Placebo

Drug: MRT-6160

First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants

This is a first-in-human study to evaluate safety, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-621 in healthy mal...

Enrolling

Healthy Participants Study

Drug: Placebo

Drug: KT-621

Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

This is a 2-cohort, fixed-sequence, 3-period, relative bioavailability, food-effect, and drug-drug interaction study. It is an open-label study evalu...

Enrolling

Healthy Volunteer

Drug: Esomeprazole

Drug: NX-5948 tablet